Mab-425

DB33677Investigational

Mab-425: Overview.

Mechanism: Pharmacologically active on Epidermal growth factor receptor
Curator reviewed
Code names: Mab-425

Resolves to

Compound

Targets

What you can answer from here — as of August 28, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Mab-425, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.